Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review
Depression is currently the fourth leading cause of disease or disability worldwide. Antidepressant is approved for the treatment of major depression (including paediatric depression), obsessive-compulsive disorder (in both adult and paediatric populations), bulimia nervosa, panic disorder and preme...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=2;spage=194;epage=212;aulast=Siddiqui |
id |
doaj-8e9878c5315d42008818b34b77f9a2eb |
---|---|
record_format |
Article |
spelling |
doaj-8e9878c5315d42008818b34b77f9a2eb2020-11-25T01:08:25ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0975-74060976-48792011-01-013219421210.4103/0975-7406.80765Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated reviewNadeem SiddiquiAndalipSandhya BawaRuhi AliObaid AfzalM Jawaid AkhtarBishmillah AzadRajiv KumarDepression is currently the fourth leading cause of disease or disability worldwide. Antidepressant is approved for the treatment of major depression (including paediatric depression), obsessive-compulsive disorder (in both adult and paediatric populations), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. Antidepressant is a psychiatric medication used to alleviate mood disorders, such as major depression and dysthymia and anxiety disorders such as social anxiety disorder. Many drugs produce an antidepressant effect, but restrictions on their use have caused controversy and off-label prescription a risk, despite claims of superior efficacy. Our current understanding of its pathogenesis is limited and existing treatments are inadequate, providing relief to only a subset of people suffering from depression. Reviews of literature suggest that heterocyclic moieties and their derivatives has proven success in treating depression.http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=2;spage=194;epage=212;aulast=SiddiquiAntidepressantdepressionheterocyclic |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nadeem Siddiqui Andalip Sandhya Bawa Ruhi Ali Obaid Afzal M Jawaid Akhtar Bishmillah Azad Rajiv Kumar |
spellingShingle |
Nadeem Siddiqui Andalip Sandhya Bawa Ruhi Ali Obaid Afzal M Jawaid Akhtar Bishmillah Azad Rajiv Kumar Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review Journal of Pharmacy and Bioallied Sciences Antidepressant depression heterocyclic |
author_facet |
Nadeem Siddiqui Andalip Sandhya Bawa Ruhi Ali Obaid Afzal M Jawaid Akhtar Bishmillah Azad Rajiv Kumar |
author_sort |
Nadeem Siddiqui |
title |
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review |
title_short |
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review |
title_full |
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review |
title_fullStr |
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review |
title_full_unstemmed |
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review |
title_sort |
antidepressant potential of nitrogen-containing heterocyclic moieties: an updated review |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Pharmacy and Bioallied Sciences |
issn |
0975-7406 0976-4879 |
publishDate |
2011-01-01 |
description |
Depression is currently the fourth leading cause of disease or disability worldwide. Antidepressant is approved for the treatment of major depression (including paediatric depression), obsessive-compulsive disorder (in both adult and paediatric populations), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. Antidepressant is a psychiatric medication used to alleviate mood disorders, such as major depression and dysthymia and anxiety disorders such as social anxiety disorder. Many drugs produce an antidepressant effect, but restrictions on their use have caused controversy and off-label prescription a risk, despite claims of superior efficacy. Our current understanding of its pathogenesis is limited and existing treatments are inadequate, providing relief to only a subset of people suffering from depression. Reviews of literature suggest that heterocyclic moieties and their derivatives has proven success in treating depression. |
topic |
Antidepressant depression heterocyclic |
url |
http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=2;spage=194;epage=212;aulast=Siddiqui |
work_keys_str_mv |
AT nadeemsiddiqui antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview AT andalip antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview AT sandhyabawa antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview AT ruhiali antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview AT obaidafzal antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview AT mjawaidakhtar antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview AT bishmillahazad antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview AT rajivkumar antidepressantpotentialofnitrogencontainingheterocyclicmoietiesanupdatedreview |
_version_ |
1725182749673783296 |